Sign for Notice Everyday    Sign Up| Sign In| Link| English|

Our Sponsors

    Receive Latest News

    Feedburner
    Share Us


    GVP- 2019 - 13th Global Pharmacovigilance & Clinical Trials

    View: 229

    Website https://globalpharmacovigilance.pharmaceuticalconferences.com | Want to Edit it Edit Freely

    Category Pharmacology;pharmacy;clinical trials;research,pharmacovigilance

    Deadline: February 20, 2019 | Date: March 28, 2019-March 29, 2019

    Venue/Country: Osaka,Japan, Japan

    Updated: 2018-10-24 12:55:36 (GMT+9)

    Call For Papers - CFP

    With the grand success of Pharmacovigilance Series of Conferences in UK, USA in consecutive years over the last several years which met with great achievement in Business Conferencing. It’s glad to announce 13th Global Pharmacovigilance & Drug Safety Summit during March 28-29, 2019 Osaka, Japan with the theme “Explore the emerging tools for process automation in pharmacovigilance”. This is a 2 day Mega Event offering Exhibition, at venue to showcase the new and emerging technologies with Keynote presentation, Oral, YRF (Student Presentation), poster, e-poster Presentations.

    We are glad to inform you that the Speaker/Delegate/Exhibitor opportunities are available at the conference. Please visit the following link, to know more about the scientific sessions and abstracts submission, PS: https://globalpharmacovigilance.pharmaceuticalconferences.com/ .If want to attend as Delegate, kindly register to the conference. For any queries , mail us at globalpharmococvigilance2019atgmail.com


    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.